Comprehensive characterization and optimization of Caco-2 cells enabled the development of a miniaturized 96-well permeability assay

References

• Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 175(3):880–885.
   PubMed Web of Science ®Google Scholar
• Behrens I, Kissel T. 2003. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Euro J Pharma Sci. 19(5):433–442.
   PubMed Web of Science ®Google Scholar
• Bunchongprasert K, Shao J. 2020. Impact of media in transport study on cell monolayer integrity and permeability. J Pharm Sci. 109(2):1145–1152. English.
   PubMed Web of Science ®Google Scholar
• Cai X, Madari S, Walker A, Paiva A, Li Y, Herbst J, Shou W, Weller H. 2019. Addition of optimized bovine serum albumin level in a high-throughput caco-2 assay enabled accurate permeability assessment for lipophilic compounds. SLAS Discov. 24(7):738–744.
   PubMed Web of Science ®Google Scholar
• Cai XM, Walker A, Cheng C, Paiva A, Li Y, Kolb J, Herbst J, Shou WS, Weller H. 2012. Approach to improve compound recovery in a high-throughput Caco-2 permeability assay supported by liquid chromatography-tandem mass spectrometry [Article. J Pharm Sci. 101(8):2755–2762. English.
   PubMed Web of Science ®Google Scholar
• Gartzke D, Fricker G. 2014. Establishment of optimized MDCK cell lines for reliable efflux transport studies. J Pharm Sci. 103(4):1298–1304. English.
   PubMed Web of Science ®Google Scholar
• Hubatsch I, Ragnarsson EGE, Artursson P. 2007. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2(9):2111–2119. English.
   PubMed Web of Science ®Google Scholar
• Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T. 2008. Quantitative atlas of membrane transporter proteins: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res. 25(6):1469–1483.
   PubMed Web of Science ®Google Scholar
• Larson B, Banks P, Sherman H, Rothenberg M. 2012. Automation of Cell-Based Drug Absorption Assays in 96-Well Format Using Permeable Support Systems [Article. J Lab Autom. 17(3):222–232. English.
   PubMedGoogle Scholar
• Oltra-Noguera D, Mangas-Sanjuan V, Centelles-Sangüesa A, Gonzalez-Garcia I, Sanchez-Castaño G, Gonzalez-Alvarez M, Casabo V-G, Merino V, Gonzalez-Alvarez I, Bermejo M. 2015. Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers. J Pharmacol Toxicol Methods. 71:21–32.
   PubMed Web of Science ®Google Scholar
• Pasquier J, Rioult D, Abu-Kaoud N, Marie S, Rafii A, Guerrouahen BS, Le Foll F. 2013. P-glycoprotein-activity measurements in multidrug resistant cell lines: single-cell versus single-well population fluorescence methods. Biomed Res Int. 2013:676845.
   PubMed Web of Science ®Google Scholar
• Prasad B, Unadkat JD. 2014. Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics. Aaps J. 16(4):634–648. English.
   PubMed Web of Science ®Google Scholar
• Qiu X, Zhang H, Lai YR. 2014. Quantitative targeted proteomics for membrane transporter proteins: method and application. Aaps J. 16(4):714–726. English.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Matsumaru T, Yamamura N, Suzuki S, Uchida Y, Tachikawa M, Terasaki T. 2015. Drug transporter protein quantification of immortalized human lung cell lines derived from tracheobronchial epithelial cells (Calu-3 and BEAS2-B), bronchiolar-alveolar cells (NCI-H292 and NCI-H441), and alveolar type II-like cells (A549) by liquid chromatography-tandem mass spectrometry. J Pharm Sci. 104(9):3029–3038.
   PubMed Web of Science ®Google Scholar
• Senarathna S, Crowe A. 2015. The influence of passage number for Caco2 cell models when evaluating P-gp mediated drug transport. Pharmazie. 70(12):798–803. English.
   PubMed Web of Science ®Google Scholar
• Skolnik S, Lin XN, Wang JL, Chen XH, He T, Zhang BL. 2010. Towards prediction of in vivo intestinal absorption using a 96-well caco-2 assay. J Pharm Sci. 99(7):3246–3265.
   PubMed Web of Science ®Google Scholar
• Taub ME, Podila L, Ely D, Almeida I. 2005. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration of P-gp activity. Drug Metab Dispos. 33(11):1679–1687.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hop C, Leung KH, Pang JM. 2000. Determination of in vitro permeability of drug candidates through a Caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry [Article. J Mass Spectrom. 35(1):71–76.
   PubMed Web of Science ®Google Scholar
• Yu HS, Cook TJ, Sinko PJ. 1997. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res. 14(6):757–762.
   PubMed Web of Science ®Google Scholar
• Zhang J, Vath M, Ferraro C, Li Y, Murphy K, Zvyaga T, Weller H, Shou W. 2013. A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening. Rapid Commun Mass Spectrom. 27(7):731–737.
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Li N, Brown PW, Ozer JS, Lai YR. 2011. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples [Article. Rapid Commun Mass Spectrom. 25(12):1715–1724. English.
   PubMed Web of Science ®Google Scholar